Compounds > methylprednisolone

methylprednisolone and imatinib mesylate

methylprednisolone has been researched along with imatinib mesylate in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (46.15)29.6817
2010's5 (38.46)24.3611
2020's2 (15.38)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Fujioka, T; Hosen, N; Ikegame, K; Kawakami, M; Kawase, I; Kim, EH; Konaka, Y; Kunitomi, A; Masuda, T; Mukouchi, C; Murakami, M; Nishida, S; Ogawa, H; Oji, Y; Oka, Y; Sugiyama, H; Taniguchi, Y; Tsuboi, A1
Matsouka, P; Monastirli, A; Pasmatzi, E; Tsambaos, D1
Shimizu, H; Shimizu, T; Ujiie, H1
Boccadoro, M; Campa, E; Dellacasa, C; Fava, C; Ferrero, D; Fumagalli, M; Mattioli, G; Perfetti, P; Pogliani, EM; Rege-Cambrin, G1
Béné, MC; Berthaud, P; Bilhou-Nabera, C; Bologna, S; Buzyn, A; Caillères, S; Castaigne, S; Coso, D; Darre, S; Delabesse, E; Delain, M; Delannoy, A; Dombret, H; Dubruille, V; Fohrer, C; Garban, F; Isnard, F; Legrand, O; Lhéritier, V; Raby, P; Raffoux, E; Reman, O; Rigal-Huguet, F; Sonet, A; Thomas, X; Turlure, P1
Grzybowski, G; Mikołajczyk, K; Samborski, W; Walkowiak, B; Zaba, R1
Haba, Y; Hanzawa, K; Itoyama, S; Kizaki, M; Mori, S; Nemoto, T; Sagawa, M; Saito, Y; Sekiguchi, Y; Tamaru, J; Tokuhira, M; Tomikawa, A; Watanabe, R1
Annus, JK; Borbényi, Z; Marton, I; Nemes, A; Pósfai, É; Vecsei, L; Vörös, E1
Beketova, TV; Naryshkin, EA; Nasonov, EL; Novoselova, TM; Volkov, MY1
Haq, MI; Nixon, J; Stanley, AJ1
Andrade, RJ; Björnsson, ES; Lucena, MI; Medina-Caliz, I1
Chen, J; Cheng, Q; Fang, Z; Jia, Q; Zhao, G1

Reviews

2 review(s) available for methylprednisolone and imatinib mesylate

ArticleYear
Imatinib mesylate use in refractory eosinophilic granulomatosis with polyangiitis: a literature review and a case report.
    Clinical rheumatology, 2018, Volume: 37, Issue:6

    Topics: Adult; Churg-Strauss Syndrome; Female; Glucocorticoids; Granulomatosis with Polyangiitis; Humans; Imatinib Mesylate; Methylprednisolone; Protein Kinase Inhibitors

2018
Comparative efficacy and safety of pharmacological interventions for severe COVID-19 patients: An updated network meta-analysis of 48 randomized controlled trials.
    Medicine, 2022, Oct-14, Volume: 101, Issue:41

    Topics: Colchicine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Doxycycline; Humans; Imatinib Mesylate; Immunization, Passive; Immunoglobulins, Intravenous; Interferon beta-1b; Ivermectin; Lopinavir; Methylprednisolone; Network Meta-Analysis; Pandemics; Pneumonia, Viral; Randomized Controlled Trials as Topic; Ritonavir

2022

Other Studies

11 other study(ies) available for methylprednisolone and imatinib mesylate

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Successful treatment of bcr/abl-positive acute mixed lineage leukemia by unmanipulated bone marrow transplantation from an HLA-haploidentical (3-antigen-mismatched) cousin.
    Bone marrow transplantation, 2003, Volume: 31, Issue:12

    Topics: Adult; Antineoplastic Agents; Benzamides; Family; Female; Genes, abl; Graft vs Host Disease; Haplotypes; HLA Antigens; Humans; Imatinib Mesylate; Immunosuppressive Agents; Leukemia, Biphenotypic, Acute; Methotrexate; Methylprednisolone; Mycophenolic Acid; Pedigree; Piperazines; Pyrimidines; Tacrolimus; Tissue Donors; Transplantation, Homologous

2003
Disseminated erythematous and pityriasiform plaques caused by imatinib mesylate.
    Acta dermato-venereologica, 2003, Volume: 83, Issue:5

    Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Benzamides; Erythema; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Methylprednisolone; Middle Aged; Piperazines; Pityriasis; Pyrimidines

2003
Cutaneous reactions to imatinib mesylate treated by topical steroid.
    American journal of hematology, 2005, Volume: 78, Issue:3

    Topics: Administration, Cutaneous; Adult; Antineoplastic Agents; Benzamides; Betamethasone; Drug Eruptions; Fluprednisolone; Humans; Imatinib Mesylate; Male; Methylprednisolone; Middle Aged; Ointments; Piperazines; Pyrimidines; Steroids

2005
Corticosteroids can reverse severe imatinib-induced hepatotoxicity.
    Haematologica, 2006, Volume: 91, Issue:6 Suppl

    Topics: Adrenal Cortex Hormones; Antineoplastic Agents; Benzamides; Chemical and Drug Induced Liver Injury; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Liver; Liver Diseases; Methylprednisolone; Piperazines; Prednisone; Pyrimidines

2006
Imatinib and methylprednisolone alternated with chemotherapy improve the outcome of elderly patients with Philadelphia-positive acute lymphoblastic leukemia: results of the GRAALL AFR09 study.
    Leukemia, 2006, Volume: 20, Issue:9

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Disease-Free Survival; Humans; Imatinib Mesylate; Methylprednisolone; Philadelphia Chromosome; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Stem Cell Transplantation; Treatment Outcome

2006
[The hypereosinophilic syndrome: case report].
    Annales Academiae Medicae Stetinensis, 2006, Volume: 52 Suppl 2

    Topics: Adult; Benzamides; Bone Marrow; Diagnosis, Differential; Eosinophils; Humans; Hydroxyurea; Hypereosinophilic Syndrome; Imatinib Mesylate; Interferons; Lymphatic Diseases; Male; Methylprednisolone; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Skin Diseases; Treatment Outcome

2006
[Acute-onset eosinophilic leukemia associated with tumor lysis syndrome after imatinib and steroid pulse therapy].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2010, Volume: 51, Issue:5

    Topics: Acute Kidney Injury; Aged, 80 and over; Benzamides; Disseminated Intravascular Coagulation; Drug Synergism; Fatal Outcome; Female; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Leukemia, Eosinophilic, Acute; Methylprednisolone; Piperazines; Pleural Effusion; Pulse Therapy, Drug; Pyrimidines; Tumor Lysis Syndrome

2010
WATERSHED INFARCTION IN HYPEREOSINOPHILIC SYNDROME: A DIAGNOSTIC DILEMMA IN FIP1L1-PDGFR ALPHA-ASSOCIATED MYELOID NEOPLASM.
    Ideggyogyaszati szemle, 2015, May-30, Volume: 68, Issue:5-6

    Topics: Adult; Anti-Inflammatory Agents; Antineoplastic Agents; Benzamides; Biomarkers, Tumor; Bone Marrow Neoplasms; Cardiomyopathies; Central Nervous System Diseases; Diagnosis, Differential; Gene Rearrangement; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Infarction; Magnetic Resonance Imaging; Male; Methylprednisolone; mRNA Cleavage and Polyadenylation Factors; Neuroprotective Agents; Piperazines; Posterior Leukoencephalopathy Syndrome; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha

2015
Imatinib and liver toxicity.
    BMJ case reports, 2018, Dec-07, Volume: 11, Issue:1

    Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Chemical and Drug Induced Liver Injury; Chemotherapy, Adjuvant; Duodenal Neoplasms; Female; Gastrointestinal Stromal Tumors; Glucocorticoids; Humans; Imatinib Mesylate; Liver Function Tests; Methylprednisolone; Middle Aged; Protein Kinase Inhibitors; Treatment Outcome

2018
Setting up criteria for drug-induced autoimmune-like hepatitis through a systematic analysis of published reports.
    Hepatology communications, 2022, Volume: 6, Issue:8

    Topics: Adalimumab; Chemical and Drug Induced Liver Injury; Diclofenac; Female; Hepatitis A; Hepatitis, Autoimmune; Humans; Imatinib Mesylate; Infliximab; Interferons; Methyldopa; Methylprednisolone; Minocycline; Nitrofurantoin

2022